Developer docs
API playgroundTry for free, no card

Search company profiles

MBC BioLabs

Full company profile

uuid0009f2v

Namestring
MBC BioLabs
Legal namestring
MBC BioLabs
Websiteurl
mbcbiolabs.com
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech incubator services, lab space rental, shared lab equipment, life science coworking, biotech startup support
Industry2 codes
PRIMARYHLAGAGAE
Process Development & Tech Transfer (Upstream/Downstream/MSAT)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biotech Lab Incubator Services
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Lab Space Rental
TypeSubscription Recurring
Description

MBC BioLabs rents laboratory space starting as small as a single lab bench, providing flexible lab space for biotech startups. Companies pay for bench space, equipment time, freezer storage, and core facility services. The model allows companies to be fast, focused, and frugal.

mbcbiolabs.com
2Mission BioCapital (Venture Capital)
TypeLicensing Royalties
Description

Built-in venture capital firm that provides funding to promising resident companies. Mission BioCapital invests in startups, creating alignment between the incubator and portfolio company success.

mbcbiolabs.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Infrastructure, Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Flexible lab bench rental with equipment access
ModelSubscriptionBilling cadenceMonthly
Notes

Companies rent space as small as a single lab bench with access to shared equipment and core facilities. Pricing varies by location and space requirements.

mbcbiolabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MBC BioLabs rents flexible laboratory space starting from a single lab bench to early-stage biotech companies across four San Francisco Bay Area locations. Residents gain access to a shared equipment library worth millions of dollars, a complete molecular biology core facility at each site, and an ecosystem of more than 500 alumni companies plus pharmaceutical and venture capital partners. The model allows startups to begin experiments on day one without building out their own lab infrastructure.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Companies can access millions of dollars of equipment without purchasing
+4 more records
Product overview1 text field

MBC BioLabs is a life-science incubator offering flexible laboratory space and shared resources for biotech startups. The core offering is modular lab bench rental at four Bay Area locations (135 Mississippi St, 953 Indiana St, 733 Industrial Rd San Carlos, 930 Brittan Ave, and 1030 Brittan Ave San Carlos), which includes access to millions of dollars of shared equipment across molecular biology, cell analysis, and analytical categories. The company operates as a platform-plus-services model, where startups can rent space as small as a single bench and immediately access a complete molecular biology core facility. Premium add-on services include the Advanced Mass Spectrometry Center (featuring Agilent QQQ and QTOF systems for proteomics and metabolomics work) and the Golden Ticket Program (which provides free lab space sponsored by pharmaceutical partners including AbbVie, Astellas, Bristol Myers Squibb, Eisai, and ONO). The company also facilitates community events, workshops, and provides operational support to help early-stage companies accelerate their research.

Product and service4 records
1Flexible Laboratory Space
CategoryLab Space Rental
Description

Rental of laboratory space starting from a single bench up to full lab suites at four San Francisco Bay Area locations, providing biotech startups immediate access to research facilities without the overhead of building their own labs.

2Shared Equipment Access
CategoryShared Lab Equipment
Description

Reservation-based access to a shared laboratory equipment library worth millions of dollars, including biosensors, cell culture systems, chromatography, flow cytometers, microscopes, PCR machines, and general lab equipment, billed by the hour.

3Advanced Mass Spectrometry Center
CategoryAnalytical Services
Description

In-house mass spectrometry facility at the 1030 Brittan location featuring Agilent 6495D QQQ and Agilent 6545XT QTOF systems paired with Agilent 1290III BioLC, providing targeted quantitation, DMPK, stability testing, ADC profiling, peptide mapping, and glycan profiling services to resident startups.

4Golden Ticket Program
CategorySponsored Lab Space Program
Description

Competitive program sponsored by pharmaceutical partners (AbbVie, Astellas, Bristol Myers Squibb, Eisai, ONO, Nitto, and others) that awards promising biotech startups one year of free lab space at MBC BioLabs, direct partnership with the sponsor, and access to the sponsor's network.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-03-30
Description

Collaboration provides resident companies access to Withum's full suite of advisory, tax, and outsourced accounting services from early-stage bookkeeping and R&D tax credits to CFO support, GAAP compliance, and audit services.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-02-28
Description

Partnership supports high-growth biotech startups as they scale, innovate, and navigate complex industry landscape with legal expertise.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Five-year strategic partnership with AbbVie across BioLabs, LabCentral and MBC BioLabs to boost innovation in key biotech clusters in US and Europe. AbbVie has been champion of shared vision for advancing biotech entrepreneurship.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-19
Description

Japan-based pharmaceutical company partnered with MBC BioLabs to strengthen global innovation in drug discovery. Collaboration aims to advance Meiji's open-innovation initiatives in infectious diseases, hematologic disorders, and immune-inflammatory diseases by engaging with MBC BioLabs entrepreneur and startup community.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-06-17
Description

Nitto Golden Ticket sponsor at MBC BioLabs. Awards promising biotech startup with free lab space and support.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Founding Partner of MBC BioLabs. Johnson & Johnson Innovation focuses on accelerating early-stage innovation and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Founding Partner and sponsor of Golden Ticket program, including Diversity Golden Ticket. AbbVie supports MBC BioLabs' mission of advancing biotech entrepreneurship through multi-year strategic partnership.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Platinum Partner sponsoring Astellas Future Innovator Prize at MBC BioLabs. Provides R&D capabilities and business leader access to winners.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Platinum Partner and sponsor of Golden Ticket program. BMS Golden Ticket awards two lab bench spots to innovative biotech startups in oncology, hematology, immunoscience, cardiovascular, neuroscience or fibrotic diseases.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Platinum Partner and Golden Ticket sponsor. Eisai interested in drug discovery platform technologies, novel targets and biology in oncology and neurology.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Platinum Partner with Bio Innovation Hub (BIH) focused on accelerating therapeutic progress through co-creation partnerships with external innovators.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Platinum Partner and Golden Ticket sponsor. ONO focuses on oncology, immunology, neurology and specialty research with high medical needs.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Agilent for Advanced Mass Spectrometry Center at 1030 Brittan location. Provides high-performance analytical support with Agilent 6495D QQQ and 6545XT QTOF systems.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

LabCentral operates shared biotech laboratory incubators in Cambridge, MA (and now abroad), offering flexible bench space, shared equipment, and a sponsor network similar to MBC BioLabs. It is the closest direct peer in the US biotech incubator category and is named alongside MBC BioLabs in the 2026 multi-region AbbVie partnership.

TypeDirect peer
Description

BioLabs runs a network of shared lab coworking sites for early-stage life-science startups across multiple US cities and Europe, with the same core model of bench rental and shared equipment access as MBC BioLabs. It is a direct competitor and named partner in the 2026 AbbVie-sponsored cross-network partnership.

TypeDirect peer
Description

Johnson & Johnson Innovation's JLABS is a global network of life-science incubators offering no-strings-attached lab space and resources to biotech startups. J&J is a founding partner of MBC BioLabs, but JLABS is also a direct competitor operating in multiple geographies.

TypeDirect peer
Description

Alexandria Real Estate's LaunchLabs provides turn-key, shared lab and office space for early-stage life-science companies in Cambridge, NYC, and other biotech hubs. It competes directly for early-stage biotech tenants with a similar flexible-bench model.

TypeDirect peer
Description

IndieBio is a biotech accelerator that provides lab space, mentorship, and seed funding to early-stage biology startups in San Francisco and New York. While more accelerator-focused, it overlaps with MBC BioLabs in serving early-stage biotech founders needing wet-lab infrastructure.

TypeRegional player
Description

Cedars-Sinai Accelerator is a Los Angeles-based healthcare/biotech accelerator offering workspace and clinical/commercial mentorship to startups. It targets a different geography than MBC BioLabs but competes for similar early-stage healthcare founders.

TypeEmerging player
Description

BioGenerator is a St. Louis-based biotech startup creator and investor that operates lab infrastructure for early-stage life-science companies. It serves a similar incubator function but in the Midwest ecosystem, with more emphasis on company creation than facility rental.

TypeEmerging player
Description

Petri is a media and community platform for early-stage biotech founders that also connects startups to lab space and resources. It overlaps with MBC BioLabs in serving biotech entrepreneurs at the pre-seed/seed stage but does not itself operate lab facilities.

TypeOthers
Description

Mission BioCapital is MBC BioLabs' integrated venture capital arm that funds promising resident companies. It is not a direct competitor but a closely affiliated capital provider that creates a unique structural alignment versus typical peer incubators.

TypeOthers
Description

Agilent is a major life-science instrumentation provider and the partner powering MBC BioLabs' Advanced Mass Spectrometry Center. It is an enabling technology supplier rather than a competitor, but its strategic involvement signals the caliber of instrumentation MBC BioLabs deploys.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks3 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MBC BioLabs

Biotech Lab Incubator Servicesmbcbiolabs.com

MBC BioLabs firmographics

Firmographics
Name
MBC BioLabs
Legal name
MBC BioLabs
Website
https://mbcbiolabs.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

MBC BioLabs industry classification

Industry
Product category
Biotech Lab Incubator Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAGAE
Process Development & Tech Transfer (Upstream/Downstream/MSAT)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)

Keywords

  • Biotech incubator services
  • Lab space rental
  • Shared lab equipment
  • Life science coworking
  • Biotech startup support

Where MBC BioLabs is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices5 records

Markets served

MBC BioLabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Lab Space Rental: MBC BioLabs rents laboratory space starting as small as a single lab bench, providing flexible lab space for biotech startups. Companies pay for bench space, equipment time, freezer storage, and core facility services. The model allows companies to be fast, focused, and frugal.
  2. Mission BioCapital (Venture Capital): Built-in venture capital firm that provides funding to promising resident companies. Mission BioCapital invests in startups, creating alignment between the incubator and portfolio company success.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyFlexible lab bench rental with equipment access

Go-to-market motion3 records

Distribution channels1 record

Marketing channels5 records

MBC BioLabs product offering

Product offering

Core offering

MBC BioLabs rents flexible laboratory space starting from a single lab bench to early-stage biotech companies across four San Francisco Bay Area locations. Residents gain access to a shared equipment library worth millions of dollars, a complete molecular biology core facility at each site, and an ecosystem of more than 500 alumni companies plus pharmaceutical and venture capital partners. The model allows startups to begin experiments on day one without building out their own lab infrastructure.

Product overview

MBC BioLabs is a life-science incubator offering flexible laboratory space and shared resources for biotech startups. The core offering is modular lab bench rental at four Bay Area locations (135 Mississippi St, 953 Indiana St, 733 Industrial Rd San Carlos, 930 Brittan Ave, and 1030 Brittan Ave San Carlos), which includes access to millions of dollars of shared equipment across molecular biology, cell analysis, and analytical categories. The company operates as a platform-plus-services model, where startups can rent space as small as a single bench and immediately access a complete molecular biology core facility. Premium add-on services include the Advanced Mass Spectrometry Center (featuring Agilent QQQ and QTOF systems for proteomics and metabolomics work) and the Golden Ticket Program (which provides free lab space sponsored by pharmaceutical partners including AbbVie, Astellas, Bristol Myers Squibb, Eisai, and ONO). The company also facilitates community events, workshops, and provides operational support to help early-stage companies accelerate their research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Flexible Laboratory Space Rental of laboratory space starting from a single bench up to full lab suites at four San Francisco Bay Area locations, providing biotech startups immediate access to research facilities without the overhead of building their own labs.
  • Shared Equipment Access Reservation-based access to a shared laboratory equipment library worth millions of dollars, including biosensors, cell culture systems, chromatography, flow cytometers, microscopes, PCR machines, and general lab equipment, billed by the hour.
  • Advanced Mass Spectrometry Center In-house mass spectrometry facility at the 1030 Brittan location featuring Agilent 6495D QQQ and Agilent 6545XT QTOF systems paired with Agilent 1290III BioLC, providing targeted quantitation, DMPK, stability testing, ADC profiling, peptide mapping, and glycan profiling services to resident startups.
  • Golden Ticket Program Competitive program sponsored by pharmaceutical partners (AbbVie, Astellas, Bristol Myers Squibb, Eisai, ONO, Nitto, and others) that awards promising biotech startups one year of free lab space at MBC BioLabs, direct partnership with the sponsor, and access to the sponsor's network.

Quantifiable outcome

  • Companies can access millions of dollars of equipment without purchasing
  • +4 more outcomes

Companies that use MBC BioLabs

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

MBC BioLabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MBC BioLabs partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered minor and core.

  • WithumminorImplementation/ SI/ Consulting Partner · 30 March 2026Collaboration provides resident companies access to Withum's full suite of advisory, tax, and outsourced accounting services from early-stage bookkeeping and R&D tax credits to CFO support, GAAP compliance, and audit services.
  • Paul Hastings LLPminorImplementation/ SI/ Consulting Partner · 28 February 2026Partnership supports high-growth biotech startups as they scale, innovate, and navigate complex industry landscape with legal expertise.
  • BioLabs (BioInnovation Labs) and LabCentralcoreStrategic or Co-development Partner · 12 January 2026Five-year strategic partnership with AbbVie across BioLabs, LabCentral and MBC BioLabs to boost innovation in key biotech clusters in US and Europe. AbbVie has been champion of shared vision for advancing biotech entrepreneurship.
  • Meiji Seika PharmacoreStrategic or Co-development Partner · 19 December 2025Japan-based pharmaceutical company partnered with MBC BioLabs to strengthen global innovation in drug discovery. Collaboration aims to advance Meiji's open-innovation initiatives in infectious diseases, hematologic disorders, and immune-inflammatory diseases by engaging with MBC BioLabs entrepreneur and startup community.
  • Nitto InnovationsminorGTM or Marketing Partner · 17 June 2024Nitto Golden Ticket sponsor at MBC BioLabs. Awards promising biotech startup with free lab space and support.
  • Johnson & Johnson Innovation (JNJ Innovation/JLabs)coreGTM or Marketing PartnerFounding Partner of MBC BioLabs. Johnson & Johnson Innovation focuses on accelerating early-stage innovation and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses.
  • AbbViecoreGTM or Marketing PartnerFounding Partner and sponsor of Golden Ticket program, including Diversity Golden Ticket. AbbVie supports MBC BioLabs' mission of advancing biotech entrepreneurship through multi-year strategic partnership.
  • Astellas Pharma Inc.coreGTM or Marketing PartnerPlatinum Partner sponsoring Astellas Future Innovator Prize at MBC BioLabs. Provides R&D capabilities and business leader access to winners.
  • Bristol Myers SquibbcoreGTM or Marketing PartnerPlatinum Partner and sponsor of Golden Ticket program. BMS Golden Ticket awards two lab bench spots to innovative biotech startups in oncology, hematology, immunoscience, cardiovascular, neuroscience or fibrotic diseases.
  • Eisai Innovation, Inc.coreGTM or Marketing PartnerPlatinum Partner and Golden Ticket sponsor. Eisai interested in drug discovery platform technologies, novel targets and biology in oncology and neurology.
  • Novo NordiskcoreGTM or Marketing PartnerPlatinum Partner with Bio Innovation Hub (BIH) focused on accelerating therapeutic progress through co-creation partnerships with external innovators.
  • ONO Pharmaceutical Co., Ltd.coreGTM or Marketing PartnerPlatinum Partner and Golden Ticket sponsor. ONO focuses on oncology, immunology, neurology and specialty research with high medical needs.
  • AgilentcoreTechnology or IntegrationPartnership with Agilent for Advanced Mass Spectrometry Center at 1030 Brittan location. Provides high-performance analytical support with Agilent 6495D QQQ and 6545XT QTOF systems.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

MBC BioLabs competitors and assessment

Company assessment

Direct peers

  • LabCentral: LabCentral operates shared biotech laboratory incubators in Cambridge, MA (and now abroad), offering flexible bench space, shared equipment, and a sponsor network similar to MBC BioLabs. It is the closest direct peer in the US biotech incubator category and is named alongside MBC BioLabs in the 2026 multi-region AbbVie partnership.
  • BioLabs (BioInnovation Labs): BioLabs runs a network of shared lab coworking sites for early-stage life-science startups across multiple US cities and Europe, with the same core model of bench rental and shared equipment access as MBC BioLabs. It is a direct competitor and named partner in the 2026 AbbVie-sponsored cross-network partnership.
  • JLABS (Johnson & Johnson Innovation): Johnson & Johnson Innovation's JLABS is a global network of life-science incubators offering no-strings-attached lab space and resources to biotech startups. J&J is a founding partner of MBC BioLabs, but JLABS is also a direct competitor operating in multiple geographies.
  • Alexandria LaunchLabs: Alexandria Real Estate's LaunchLabs provides turn-key, shared lab and office space for early-stage life-science companies in Cambridge, NYC, and other biotech hubs. It competes directly for early-stage biotech tenants with a similar flexible-bench model.
  • IndieBio: IndieBio is a biotech accelerator that provides lab space, mentorship, and seed funding to early-stage biology startups in San Francisco and New York. While more accelerator-focused, it overlaps with MBC BioLabs in serving early-stage biotech founders needing wet-lab infrastructure.

Regional players

  • Cedars-Sinai Accelerator: Cedars-Sinai Accelerator is a Los Angeles-based healthcare/biotech accelerator offering workspace and clinical/commercial mentorship to startups. It targets a different geography than MBC BioLabs but competes for similar early-stage healthcare founders.

Emerging players

  • BioGenerator: BioGenerator is a St. Louis-based biotech startup creator and investor that operates lab infrastructure for early-stage life-science companies. It serves a similar incubator function but in the Midwest ecosystem, with more emphasis on company creation than facility rental.
  • Petri (Petri.com / Petri.bio): Petri is a media and community platform for early-stage biotech founders that also connects startups to lab space and resources. It overlaps with MBC BioLabs in serving biotech entrepreneurs at the pre-seed/seed stage but does not itself operate lab facilities.

Others

  • Mission BioCapital: Mission BioCapital is MBC BioLabs' integrated venture capital arm that funds promising resident companies. It is not a direct competitor but a closely affiliated capital provider that creates a unique structural alignment versus typical peer incubators.
  • Agilent Technologies: Agilent is a major life-science instrumentation provider and the partner powering MBC BioLabs' Advanced Mass Spectrometry Center. It is an enabling technology supplier rather than a competitor, but its strategic involvement signals the caliber of instrumentation MBC BioLabs deploys.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights7 records

Customer concentration

MBC BioLabs social profiles

Digital presence

MBC BioLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MBC BioLabs leadership team

Management profile

Number of profiles

Profiles3 records

MBC BioLabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MBC BioLabs M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MBC BioLabs

What does MBC BioLabs do?

MBC BioLabs rents flexible laboratory space starting from a single lab bench to early-stage biotech companies across four San Francisco Bay Area locations. Residents gain access to a shared equipment library worth millions of dollars, a complete molecular biology core facility at each site, and an ecosystem of more than 500 alumni companies plus pharmaceutical and venture capital partners. The model allows startups to begin experiments on day one without building out their own lab infrastructure.

Is MBC BioLabs a public or private company?

MBC BioLabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MBC BioLabs founded?

MBC BioLabs was founded in 2013. It employs 11 to 50 people.

Where is MBC BioLabs based?

MBC BioLabs is headquartered in San Francisco, United States, in the North America region.

How does MBC BioLabs make money?

Two revenue lines are on record. Lab Space Rental is the primary driver. The others are mission BioCapital (Venture Capital).

Who are MBC BioLabs's main competitors?

Direct peers on record are LabCentral, BioLabs (BioInnovation Labs), JLABS (Johnson & Johnson Innovation), Alexandria LaunchLabs and IndieBio. Cedars-Sinai Accelerator is listed as a regional player. Emerging players are BioGenerator and Petri (Petri.com / Petri.bio). Others are Mission BioCapital and Agilent Technologies.

Does MBC BioLabs have an API?

No public API is recorded for MBC BioLabs.

What industry is MBC BioLabs in?

MBC BioLabs's product category is Biotech Lab Incubator Services. Its primary akta.pro industry code is HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsMBC BioLabs bets on AI boom to boost biotech startupsMBC BioLabs is leveraging its location in San Francisco's Dogpatch neighborhood, near the AI hub of Mission Bay, to support biotech startups. The article emphasizes the strategic advantage of being close to an AI center.SynBioBetaLowering the Barriers to Biotech: How Douglas Crawford Built an Engine for Scientific EntrepreneursDouglas Crawford, founder of MBC BioLabs, has built a shared laboratory network that has helped launch over 500 biotech companies, facilitated 176 clinical trials, and enabled portfolio companies to collectively raise more than $20 billion since its origins in 2007. Crawford also serves as Managing Partner of Mission BioCapital, a $275 million venture fund investing in early-stage life sciences, and helped launch the QB3 Garage at UCSF as the first technology incubator in the University of California system. While scientific innovation continues to accelerate, the article notes that funding conditions for early-stage companies have tightened as many generalist investors who entered life sciences during the pandemic have retreated.Life Science Company NewsJapan's Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discoveryJapan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs, a private organization supporting biotech startups in California's San Francisco Bay Area. Through this collaboration, Meiji Seika Pharma aims to advance its open-innovation initiatives and strengthen R&D in priority therapeutic areas including infectious diseases, hematologic diseases, and immune-inflammatory diseases. The company expects to discover innovative drug discovery seeds and accelerate external collaborations by engaging with the entrepreneur and startup community at MBC BioLabs.BioSpaceMeiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug DiscoveryMeiji Seika Pharma Co., Ltd. has announced a partnership with MBC BioLabs to enhance global innovation in drug discovery. This collaboration aims to strengthen Meiji Seika's research and development efforts in areas such as infectious and hematologic diseases, leveraging MBC BioLabs' resources to engage with biotech entrepreneurs. The partnership reflects Meiji Seika's commitment to advancing its open-innovation initiatives and accelerating the commercialization of new therapies.PharmiWeb.comMeiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug DiscoveryMeiji Seika Pharma has entered into a partnership agreement with MBC BioLabs, a biotech incubator based in California's San Francisco Bay Area, to advance its open-innovation initiatives and strengthen drug discovery research. Through this collaboration, Meiji Seika Pharma aims to engage with entrepreneurs and startup companies at MBC BioLabs to discover innovative drug discovery seeds in priority therapeutic areas including infectious diseases, hematologic diseases, and immune-inflammatory diseases. The partnership is intended to draw new ideas from global innovation activities and deepen collaboration with innovation hubs in Japan and overseas.LinkedIn#fundingnews #vcfunding #deeptech #lifesciences #ai #scientificdiscovery #nordictechThe article reports on the Biotech Funding 2025 seminar in the Bay Area hosted by BioPioneers, MBC BioLabs, and SVB, discussing trends in biotech investment and government funding opportunities.PR NewswireAstellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna BioAstellas and MBC BioLabs announced DeepSeq.AI and Serna Bio as winners of the sixth annual Astellas Future Innovator Prize. The award provides one-year priority lab access in San Francisco and Astellas' R&D capabilities. DeepSeq.AI focuses on AI-driven large molecule discovery, while Serna Bio develops small molecules to upregulate protein translation.GlobeNewswireRetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabsRetinalGenix Technologies announced a new laboratory lease with MBC BioLabs in San Carlos, California, with an option for Mission BioCapital to invest. The company will use the facility to develop its DNA/RNA/GPS Pharmaco-Genetic Mapping platform and repurpose drugs for dementia, parkinsonism, and macular degeneration.PR NewswireAstellas Venture Management and MBC BioLabs Announce the 5th Annual Astellas Future Innovator PrizeAstellas Venture Management and MBC BioLabs have announced the 5th annual Astellas Future Innovator Prize, offering biotech start-ups one year of priority access to MBC BioLabs' laboratory facilities in San Francisco along with access to Astellas' R&D expertise and business leaders. The competition, open from September 18 to November 3, 2023, will award up to two prizes to companies whose innovations align with Astellas' focus areas including Blindness & Regeneration, Mitochondria, Genetic Regulation, Immuno-Oncology, Cell Therapy, and Targeted Protein Degradation. Last year's winners were Bespoke Therapeutics and Cellinfinity, selected for their potential to deliver therapeutic advances for unmet medical needs.PR NewswireONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership with LabCentral and MBC BioLabsONO Pharma USA announced a 2023 Golden Ticket competition with LabCentral and MBC BioLabs, offering lab space and mentorship to early-stage life sciences startups. Applications are due May 26 for LabCentral and May 12 for MBC BioLabs, with winners receiving a $50,000 credit or one-year free lab space.